The aim of this study was to review empirical studies examining associations between
candidate genes and adverse events (AEs) from methylphenidate (MPH) use in children and …

Stimulant medication has long been effective in treating attention-deficit/hyperactivity
disorder (ADHD) and is currently the first-line pharmacological treatment for children. Both …

Attention deficit/hyperactivity disorder (ADHD), a common children's behavioral disorder, is
characterized by inattention, hyperactivity and impulsivity. The disorder is thought to stem …

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in
which a significant proportion of patients do not respond to treatment. The objective of this …

To compile an inventory of European healthcare databases with potential to study long-term
effects of methylphenidate (MPH) in patients with attention deficit hyperactivity disorder …

Objective: The aim of the current study was to determine various aspects of methylphenidate
adverse reactions in children with attention deficit-hyperactivity disorder (ADHD) in Iran …

Background: Attention-deficit hyperactivity disorder (ADHD) is the most common childhood-
onset neurodevelopmental disorder, and methylphenidate (MPH) is considered one of the …

Objective: We explored two different methods of determining adverse events (AEs) among
methylphenidate (MPH)-treated adolescents with attention-deficit/hyperactivity disorder …

Methylphenidate (MPH) is the most frequently used pharmacological treatment in children
with attention-deficit/hyperactivity disorder. However, a considerable interindividual …

Attention-deficit/hyperactivity disorder (ADHD) is a common childhood onset
neuropsychiatric disorder with a complex and heterogeneous symptomatology. Persistence …